Industry is gathering scientific data to approach the regulator, DCGI, for a review of the suspension order.
Lupin was the top gainer after the USFDA cleared its Goa facility
This recognition is a testimony of India's strong belief in promoting entrepreneurship
In the US, the ratio of the CEO to average worker pay ratio was 373:1 in 2014.
The turmoil on the Street and a continued fall of the rupee may affect growth stocks, pushing equity investors back to the relative safety of defensive counters, or forcing them to flee markets, or both.
Ajit Mishra, vice president, research, Religare Broking, answers your queries.
The Commonwealth gold medallist said that women must focus on developing their inner strength.
Ajit Mishra, vice president, Research, Religare Broking, answers your queries.
While sales in the domestic market declined 4.2 per cent during the April-July period, exports grew steadily at 9.5 per cent during the same period.
Rosier year-end seen for Indian pharma thanks to faster US approvals.
In its report 'Global Top Picks', Barclays expects the current bull market in global equities to continue, generating a total return of 9 per cent in 2015.
Indian government has extended price caps to 39 more medicines ranging from commonly used diabetes drugs to antibiotics.
Among the lot, Rallis India, Escorts, Jubilant Life Sciences, and Crisil added half of the total gains made in the ace stock-picker's portfolio.
Who do you think can be cast in the desi version of Harry Potter?
Novartis said it is partnered with generic drugmaker Lupin Ltd to sell the drug in India
Sun Pharma and Dr Reddy's top list in terms of those who face most class-action litigation
Currently, the govt directly caps prices of 348 formulations at the average price of all medicines in a particular segment with at least 1% market share
Participants will watch out for the Brexit poll outcome in the late morning trades tomorrow.
This helps consumers check the authenticity of drugs simply by sending SMSes.
Pharma was the top losing index amid worries about their earnings outlook with Lupin down over 4%
A record net inflow in Indian equities in the financial year ending March 2013 helped foreign investors widen their grip.
In the last one month, Indian pharmaceutical company Lupin has won US Food and Drug Administration nod for three of its contraceptive pills, and has at least nine approvals pending with the regulator.
Ajit Mishra, vice president, research, Religare Broking, answers your stockmarket queries.
The ace investor has gone ahead and selectively raised stake in some of these.
Regulator says fee would enable it to quicken approval process.
USFDA has extended the timeline for granting tentative approval to generic drug applications filed under Para IV of its rules by 10 months.
Companies such as Dr Reddy's Laboratories, Sun Pharmaceutical, Lupin and Ranbaxy striving to capitalise on opportunities created by pro-generic health care reforms in the US market are facing pricing pressure as the health care supply chain is undergoing consolidation.
Ajit Mishra, vice president, Research, Religare Broking, answers your queries
Currently, the investor and his family's net worth in listed firms stands at Rs 8,517 crore, compared to Rs 8,388 crore as of March 31, 2020.
This move could cost $299 million a year for Indian pharma players.
According to industry estimates, the sector's revenue would increase eight-10 per cent in 2013-14, against 12 per cent in 2012-13.
The list acknowledges the 'inroads women are making in the business world'.
The brokerage said it expected corporate earnings to turn around.
Samina Vaziralli, daughter of joint Managing Director M K Hamied, was inducted into the company management. Cipla joins the league of major companies such as Lupin, Wockhardt, Elder Pharma, Piramal Healthcare and JB Chemicals in this regard.
Indian pharmaceutical companies, which always wanted a big share in the global copycat drug market, are betting high on the oral contraceptive (OC) market in America.
Companies asked to give data for three batches instead of one; move may lead to significant rise in development cost of generics
With an m-cap of Rs 31,744 crore, IRCTC stood at 96th position in the overall market capitalisation ranking, the BSE data shows.
India offices of MNCs like DHL, Google and Marriott ranked among the top workplaces in Asia.
The anti-depressant drug market in the US is primarily ruled by Effexor XR (Venlafaxine) of Wyeth (now owned by Pfizer).